Cargando…
Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial
BACKGROUND: Efficacy data on drug‐eluting stents (DES) versus bare‐metal stents (BMS) in saphenous vein grafts are controversial. We aimed to compare DES with BMS among patients undergoing saphenous vein grafts intervention regarding long‐term outcome. METHODS AND RESULTS: In this multinational tria...
Autores principales: | Fahrni, Gregor, Farah, Ahmed, Engstrøm, Thomas, Galatius, Søren, Eberli, Franz, Rickenbacher, Peter, Conen, David, Mueller, Christian, Pfister, Otmar, Twerenbold, Raphael, Coslovsky, Michael, Cattaneo, Marco, Kaiser, Christoph, Mangner, Norman, Schuler, Gerhard, Pfisterer, Matthias, Möbius‐Winkler, Sven, Jeger, Raban V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763393/ https://www.ncbi.nlm.nih.gov/pubmed/33032485 http://dx.doi.org/10.1161/JAHA.120.017434 |
Ejemplares similares
-
First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study
por: Jeger, Raban, et al.
Publicado: (2016) -
Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials
por: Bjerking, Louise Hougesen, et al.
Publicado: (2019) -
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial
por: Seeger, Julia, et al.
Publicado: (2023) -
Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials
por: Hansen, Kim Wadt, et al.
Publicado: (2019) -
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II
por: Jeger, Raban V., et al.
Publicado: (2019)